ABSTRACT. Fetal alcohol syndrome is the leading known cause of mental retardation. The syndrome, defined as growth retardation, midface hypoplasia, and neurologic dysfunction, represents only part of the spectrum of fetal alcohol effects. The biochemical mechanism of teratogenesis is unknown. In adults, metabolites of ethanol, FAEE, are known to accumulate in major organs. The formation of FAEE is catalyzed by a family of enzymes, FAEE synthases. Our hypothesis is that accumulation of FAEE in the embryo results in fetal alcohol syndrome. We have developed assays for FAEE and FAEE synthase activity using mg of tissue. Using these assays, we have shown the following: Human placenta, mouse placenta, heart, and liver are active in catalyzing the formation of FAEE. One h after maternal ethanol administration on gestational d 14, mouse placenta and fetuses accumulated significant quantities of FAEE. The fatty acid incorporated into FAEE was tissue dependent. Tissues from pregnant animals given ethanol on gestational d 7 showed persistence of FAEE on gestational d 14. We conclude that: 1 ) human and mouse placentas have significant FAEE synthase activity, 2) mouse heart, liver, placenta, and fetal tissues accumulate significant amounts of FAEE after maternal ethanol exposure, 3) there is tissue specificity for the fatty acid incorporated into FAEE, and 4) FAEE may persist for 7 d in placentas. These results provide a basis for further research into the role of FAEE in the development of fetal alcohol syndrome. (Pediatr Res 31: 492-495, 1992) 
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The mechanism of ethanol-induced teratogenesis is unknown, and current hypotheses include altered placental nutrient transport, fetal hypoxia due to umbilical artery constriction and increased oxygen consumption secondary to ethanol, abnormal muscle organogenesis, prostaglandin and fetal CAMP effects, and altered hormone metabolism (5) . However, currently available data do not identify the primary site of action for alcohol or any biochemical mechanism of fetal alcohol toxicity.
Ethanol metabolism in mammals occurs primarily in the liver via two different pathways, oxidation of ethanol to acetaldehyde by either ADH or the microsomal ethanol-oxidizing system (6) .
Nonoxidative metabolism of ethanol to FAEE occurs in both liver and extrahepatic tissues (7) and is catalyzed by FAEE synthases. These lipids have been shown to bind to mitochondria in intact cells and to uncouple oxidative phosphorylation in mitochondrial preparations in vivo (8) . Synthesis and accumulation of FAEE in human pancreas, liver, adipose tissue, heart, bone marrow, peripheral leukocytes, cerebral cortex, skeletal muscle, and aorta after ethanol ingestion have been demonstrated and may represent a mechanism for ethanol-induced toxicity in organs lacking ADH (9) . Thus, this pathway may play a role in the pathophysiology of alcohol-induced organ damage.
The nonoxidative metabolism of ethanol in fetal and placental tissues has not previously been described. Existing experimental models for FAS include animal models and cell culture systems. In pregnant C57B1/6J mice, ethanol administration on d 7 results in eye abnormalities similar to those seen in humans: ptosis, anterior segment dysgenesis, and optic nerve dysplasia (10) . Additionally, in rats fed 35% of their calories as ethanol, embryonal neural division and migration were affected in the cerebral cortex, and behavioral effects were observed (1 1). In vitro, ethanol inhibits process formation in CNS sensory neurons and production of neurotrophic factors (1 2). The biochemical basis for these findings has not been elucidated. ADH is virtually absent in the fetus, and ethanol equilibrates rapidly across the placenta, resulting in exposure of fetal tissue to ethanol levels that have been shown to result in FAEE accumulation in adults ( 13) .
Our hypothesis is that accumulation of FAEE may cause or contribute to the embryopathy of FAS. The current experiments were designed to determine whether nonoxidative ethanol metabolism and FAEE accumulation occur in fetal and placental tissue in the C57BI/6J mouse model of FAS and whether human placenta contains FAEE synthase activity.
MATERIALS AND METHODS
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Tissues. Human placenta obtained within an hour of delivery Received September 9, 199 1; accepted December 18, 199 1.
was minced, washed with ice-cold normal saline, and kept frozen .
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and fetuses were combined. Tissues were homogenized in ice-
cold 10 mM Tris, pH 8.0, and 1 mM mercaptoethanol with a o polytron (Brinkmann Instruments, Westbury, NY) for 30 s.
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0.3
FAEE was quantitated as previously described (15) . Briefly, of oleic acid. The assay was performed as described in Materials and Methods. Insert, The data has been replotted in a double reciprocal plot RESULTS and the Km has been calculated for oleic acid.
FAEE synthase in human placenta. Term human placenta contains FAEE synthase activity. As shown in Figure 1 , the activity is linear to 0.4 mg of protein. The activity is also linear with time to at least 100 min and is abolished by boiling for 5 min (Fig. 2) . At pH 7.5, the Km for oleic acid is 0.4 mM ( 3). In the absence of ethanol, no FAEE are formed (data not shown). These results demonstrate that the FAEE synthase activity of term human placenta is likely to be enzymatic. The Km of 0.4 mM for oleic acid compares with a Km of 0.23 mM of the major human myocardium FAEE synthase (16) .
FAEE synthase in mouse placenta, heart, and liver. Mouse tissues were also examined for presence of FAEE synthase activity. As shown in Figure 4 , gestational d 14 placenta (1.2 nmol/ h/mg protein) is as active as maternal heart (1.1 nmol/h/mg protein). In comparison, liver is almost twice as active (3.9 nmoll h/mg protein).
FAEE accumulation in adult, fetal, and placental mouse tissues. C57B1/6J mice were used to study the association of FAEE accumulation and development of FAS. In initial studies, dams were given ethanol or saline as described in Materials and Methods on gestational d 14. FAEE were quantitated in the maternal heart and liver, placentas, and fetuses by acetone extraction, thin-layer chromatography, and gas chromatography. Two representative gas chromatographs of placental FAEE are shown in Figure 5 . The placenta of the saline-treated animal shows a complete absence of FAEE, whereas the ethanol-exposed placenta clearly has a new peak corresponding to ethyl stearate. The identity of this lipid as ethyl stearate has been confirmed by gas chromatography-mass spectroscopy (results not shown). FAEE can be quantitated by comparison to the internal standard. Fig. 4 . Mouse placenta, heart, and liver FAEE synthase activity. Tissues were assayed as described in Materials and Methods. Placentas from one litter were pooled before homogenization. Error bars represent the SEM. 
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Results from maternal tissues and placentas are shown in Figure  6 . These results show that FAEE accumulates in both maternal tissues and placenta after maternal exposure to ethanol. Of note, the fatty acyl moieties of FAEE are different in the different tissues. Placenta preferentially accumulates ethyl stearate, adult liver accumulates ethyl stearate and ethyl oleate, and heart accumulates ethyl oleate.
Fetal FAEE accumulation is shown in Figure 7 . Marked accumulation of FAEE occurs in ethanol-exposed fetal animals (10.9-15.6 nmol total FAEE/g tissue). FAEE of predominantly ethyl palmitate (2.7-3.7 nmol/g tissue), ethyl stearate (4.0-5.5 nmol/g tissue), and ethyl oleate (2.1-2.7 nmol/g tissue) could be detected. 7 placenta. The presence of FAEE synthase in placenta on gestational d 7 with resultant FAEE accumulation and persistence of FAEE for at least 7 d was suggested by the following experiment. Dams were treated with ethanol either on gestational d 7 only or on d 7 and 14. Animals were killed on d 14, 2 h after the last ethanol dose, and tissues were examined for FAEE (Fig. 8) . Animals treated on d 7 and 14 showed FAEE accumulation in placenta, heart, and liver comparable to results in Figure 2 . Again, placenta preferentially Five animals (1-5) were administered ethanol as described in Materials and Methods, and two animals (6 and 7 ) were given saline. The placentas, maternal heart, and liver were isolated, and FAEE was extracted and quantitated. Five animals (1-5) were given ethanol as described in Materials and Methods, and two animals (6 and 7 ) were given saline. The fetuses were removed, and FAEE was extracted and quantitated. The fetuses from animal CB4 were analyzed individually. These results are not shown here. accumulated ethyl stearate, whereas heart and liver accumulated ethyl oleate. However, tissues obtained on gestational d 14 from animals treated only on gestational d 7 still had significant quantities of FAEE present. This result suggests the presence of FAEE synthase in d 7 placenta with resultant FAEE accumulation. Additionally, the presence of residual FAEE 7 d after ethanol exposure suggests that FAEE in placenta have a half-life of at least 50-80 h. A half life of 16 h has been measured in rabbit adipose tissue (1 7).
FAEE synthase and FAEE in d
MECHANISM O F ETHANOL TERATOGENESIS
FAS is a global disorder with multiple organ systems affected. In a survey of 248 diagnosed cases of FAS, abnormalities were noted in the CNS, the eyes, the craniofacial structures, the cardiac system, and the genitourinary system. The CNS appears to be particularly sensitive, with effects on intelligence quotient noted with maternal "social drinking" (1 8) and errors in neuronal and glial migration noted on neuropathologic examinations of children with FAS (19) . The ocular malformations occur in almost 90% of humans with FAS (20) , with the most frequently observed malformations being hypoplasia of the optic nerve and retinal vessel tortuosity resulting in decreased visual acuity.
The biochemical basis for these effects remains unknown, despite well-characterized animal models for the development of this syndrome. In the C57B1/6J mouse line, two doses of ethanol result in eye abnormalities consistent with FAS in 50% of the pups, which span the range seen in humans, including ptosis, microphthalmia, anterior segment dysgenesis, and optic nerve dysplasia (10, 21) . In rats fed 35% of their calories as ethanol, both neuronal division and migration in the cerebral cortex were affected in the embyros (1 1).
Given the virtual lack of ADH in fetal tissues, the short halflife of ethanol in the blood, and the effects observed at low doses of ethanol, a direct effect of ethanol and/or its oxidative metabolites does not seem likely to be the major mechanism for FAS. This study demonstrates for the first time the presence of a nonoxidative metabolite of ethanol in fetal tissues. Specifically, we have shown the accumulation of FAEE in fetal tissue of the C57B1/6J mouse model of FAS, using doses of ethanol previously shown to result in morphologic abnormalities consistent with FAS. Identification of these lipids may represent a useful marker for FAS, and their accumulation may have a toxic effect on cellular metabolism directly resulting in the developmental abnormalities of FAS.
We also demonstrated the accumulation of these lipids in placenta and maternal heart and liver after ethanol exposure. The tissue specificity of FAEE in these samples may reflect tissue expression of different types of FAEE synthase or different fatty acid substrate pools in each tissue. In addition, the persistence of measurable levels of these lipids for at least 7 d after exposure is noteworthy. Thus, the effects of alcohol toxicity may be of longer duration than reflected by blood alcohol levels.
Interaction between FAEE and cholesterol metabolism has been previously suggested (7) . Interestingly, further interactions have recently been described in Fu5AH rat hepatoma cells (22). The FFA released from FAEE in this cell line are preferentially incorporated into cholesterol esters. These findings suggest further interactions between ethanol and cholesterol metabolism. The existence and significance of these interactions remain to be elucidated in fetal and placenta tissues.
Previous studies have described the copurification of FAEE synthase and GST activities from human heart and the sequence similarities between these two enzymes (23, 24) . GST is known to be abundant in placenta. The tissue specificity of GST enzymes may be the basis for the tissue specificity of FAEE described here. However, a recent article has failed to confirm the copurification of GST and FAEE synthase activities (25) . Therefore, the relationship of FAEE synthases to the GST protein family (26, 27) will need further evaluation.
These studies have also identified for the first time FAEE synthase activity in human placenta. We have demonstrated that . .
to that of the hukan myocardial enzyme.
We conclude that: I ) human and mouse placentas have significant FAEE synthase activity, 2) mouse heart, liver, placenta, and fetal tissues accumulate significant amounts of FAEE after maternal ethanol exposure, 3) there is tissue specificity for the fatty acid incorporated into FAEE, and 4) FAEE may persist for 7 d in placentas. These results provide a basis for further research into the role of FAEE in the development of FAS.
